A detailed history of Bartlett & Co. Wealth Management LLC transactions in Organon & Co. stock. As of the latest transaction made, Bartlett & Co. Wealth Management LLC holds 100 shares of OGN stock, worth $1,473. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 165 39.39%
Holding current value
$1,473
Previous $3.42 Million 44.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$18.65 - $23.03 $1,212 - $1,496
-65 Reduced 39.39%
100 $1.91 Million
Q2 2024

Jul 12, 2024

SELL
$17.45 - $21.96 $2,652 - $3,337
-152 Reduced 47.95%
165 $3.42 Million
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $20,399 - $32,267
-1,863 Reduced 85.46%
317 $4.59 Million
Q3 2023

Feb 14, 2024

SELL
$16.59 - $23.77 $2,223 - $3,185
-134 Reduced 5.79%
2,180 $37.8 Million
Q2 2023

Feb 14, 2024

SELL
$19.27 - $24.63 $1,849 - $2,364
-96 Reduced 3.98%
2,314 $48.2 Million
Q1 2023

Feb 14, 2024

SELL
$21.42 - $32.08 $5,162 - $7,731
-241 Reduced 9.09%
2,410 $56.7 Million
Q4 2022

Feb 14, 2024

SELL
$23.31 - $28.61 $3,659 - $4,491
-157 Reduced 5.59%
2,651 $74 Million
Q3 2022

Feb 14, 2024

SELL
$23.4 - $34.25 $13,572 - $19,865
-580 Reduced 17.12%
2,808 $65.7 Million
Q2 2022

Feb 14, 2024

SELL
$31.66 - $38.9 $253 - $311
-8 Reduced 0.24%
3,388 $114 Million
Q1 2022

Feb 14, 2024

SELL
$30.45 - $39.36 $13,519 - $17,475
-444 Reduced 11.56%
3,396 $119 Million
Q3 2021

Feb 13, 2024

SELL
$28.63 - $35.64 $121,448 - $151,184
-4,242 Reduced 52.49%
3,840 $126 Million
Q2 2021

Feb 13, 2024

BUY
$28.45 - $38.0 $229,932 - $307,116
8,082 New
8,082 $245 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Bartlett & Co. Wealth Management LLC Portfolio

Follow Bartlett & Co. Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.